Industry Growth Insights published a new data on “Personalized Medical Care Market”. The research report is titled “Personalized Medical Care Market research by Types (Diagnostics, Therapies), By Applications (Oncology, Neurosciences, Immunology, Respiratory, Others), By Players/Companies Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation, Biomrieux SA, Cepheid, IBM, Qiagen, Thermo Fisher Scientific, Randox Laboratories, Almac Group, Healthcore”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Personalized Medical Care Market Research Report
By Type
Diagnostics, Therapies
By Application
Oncology, Neurosciences, Immunology, Respiratory, Others
By Companies
Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation, Biomrieux SA, Cepheid, IBM, Qiagen, Thermo Fisher Scientific, Randox Laboratories, Almac Group, Healthcore
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Personalized Medical Care Market Report Segments:
The global Personalized Medical Care market is segmented on the basis of:
Types
Diagnostics, Therapies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Neurosciences, Immunology, Respiratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Roche
- Labcorp
- Abbott Laboratories
- Novartis
- Illumina
- GE Healthcare
- Intel Corporation
- Biomrieux SA
- Cepheid
- IBM
- Qiagen
- Thermo Fisher Scientific
- Randox Laboratories
- Almac Group
- Healthcore
Highlights of The Personalized Medical Care Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostics
- Therapies
- By Application:
- Oncology
- Neurosciences
- Immunology
- Respiratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Personalized Medical Care Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Personalized medical care is a type of health care that takes into account the unique needs of each individual. This includes everything from tailoring treatments to monitoring patientsu2019 health closely. Personalized medical care can help improve the quality of life for those who receive it, and it can also reduce the cost and time spent on traditional healthcare services.
Some of the major companies in the personalized medical care market are Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation, Biomrieux SA, Cepheid, IBM, Qiagen, Thermo Fisher Scientific, Randox Laboratories, Almac Group, Healthcore.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Personalized Medical Care Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Personalized Medical Care Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Personalized Medical Care Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Personalized Medical Care Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Personalized Medical Care Market Size & Forecast, 2018-2028 4.5.1 Personalized Medical Care Market Size and Y-o-Y Growth 4.5.2 Personalized Medical Care Market Absolute $ Opportunity
Chapter 5 Global Personalized Medical Care Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Personalized Medical Care Market Size Forecast by Type
5.2.1 Diagnostics
5.2.2 Therapies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Personalized Medical Care Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Personalized Medical Care Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Neurosciences
6.2.3 Immunology
6.2.4 Respiratory
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Personalized Medical Care Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Personalized Medical Care Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Personalized Medical Care Analysis and Forecast
9.1 Introduction
9.2 North America Personalized Medical Care Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Personalized Medical Care Market Size Forecast by Type
9.6.1 Diagnostics
9.6.2 Therapies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Personalized Medical Care Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Neurosciences
9.10.3 Immunology
9.10.4 Respiratory
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Personalized Medical Care Analysis and Forecast
10.1 Introduction
10.2 Europe Personalized Medical Care Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Personalized Medical Care Market Size Forecast by Type
10.6.1 Diagnostics
10.6.2 Therapies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Personalized Medical Care Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Neurosciences
10.10.3 Immunology
10.10.4 Respiratory
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Personalized Medical Care Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Personalized Medical Care Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Personalized Medical Care Market Size Forecast by Type
11.6.1 Diagnostics
11.6.2 Therapies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Personalized Medical Care Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Neurosciences
11.10.3 Immunology
11.10.4 Respiratory
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Personalized Medical Care Analysis and Forecast
12.1 Introduction
12.2 Latin America Personalized Medical Care Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Personalized Medical Care Market Size Forecast by Type
12.6.1 Diagnostics
12.6.2 Therapies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Personalized Medical Care Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Neurosciences
12.10.3 Immunology
12.10.4 Respiratory
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Personalized Medical Care Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Personalized Medical Care Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Personalized Medical Care Market Size Forecast by Type
13.6.1 Diagnostics
13.6.2 Therapies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Personalized Medical Care Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Neurosciences
13.10.3 Immunology
13.10.4 Respiratory
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Personalized Medical Care Market: Competitive Dashboard
14.2 Global Personalized Medical Care Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Roche
14.3.3 Labcorp
14.3.4 Abbott Laboratories
14.3.5 Novartis
14.3.6 Illumina
14.3.7 GE Healthcare
14.3.8 Intel Corporation
14.3.9 Biomrieux SA
14.3.10 Cepheid
14.3.11 IBM
14.3.12 Qiagen
14.3.13 Thermo Fisher Scientific
14.3.14 Randox Laboratories
14.3.15 Almac Group
14.3.16 Healthcore